Abstract

We report data showing the incidence of new coronary events in diabetics with prior myocardial infarction (MI), nondiabetics with prior MI, diabetes with no coronary artery disease (CAD), and nondiabetics with no CAD who were treated with and without statins. We investigated-in an observational prospective study of 274 diabetics and 386 nondiabetics with peripheral arterial disease, mean age years, and a serum low-density lipoprotein cholesterol level of >/=125 mg/dl-the incidence of new coronary events in diabetics with prior MI, nondiabetics with prior MI, diabetics with no CAD, and nondiabetics with no CAD who were treated with and without statins. Follow-up was months. In patients treated with statins, the incidence of new coronary events was 73% in diabetics with prior MI (group 1), 37% in nondiabetics with prior MI (group 2), 57% in diabetics with no CAD (group 3), and 27% in nondiabetics with no CAD (group 4). In patients treated with no lipid-lowering drug, the incidence of new coronary events was 91% in diabetics with prior MI (group 5), 72% in nondiabetics with prior MI (group 6), 86% in diabetics with no CAD (group 7), and 52% in nondiabetics with no CAD (group 8). Significant p values were p<.0001 for group 1 versus 2, group 7 versus 8, and group 2 versus 6; p=.0006 for group 3 versus 4; p=.0007 for group 3 versus 7; p=.001 for group 5 versus 6; p=.002 for group 4 versus 8; p=.003 for group 1 versus 5; p=.015 for group 2 versus 3; and p=.047 for group 6 versus 7. In patients treated with and without statins, diabetics with no CAD had a higher incidence of new coronary events than did nondiabetics with prior MI.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call